LncRNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma t
- This topic has 0 replies, 1 voice, and was last updated 5 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
LncRNA MIR22HG inhibits cell proliferation and migration in cholangiocarcinoma through negatively regulating Wnt/β-catenin signaling pathway.
https://www.ncbi.nlm.nih.gov/pubmed/30856284
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.